The quarterly adjustment of the MSCI Index excludes 15 Hong Kong stocks. The effective date is scheduled for early June
① Which individual stocks will MSCI China adjust quarterly? ② How much impact does the MSCI Index have on the market?
Strong inflow of foreign capital is another trend vane: Middle Eastern tycoons increase their presence in China, and multinational sovereign wealth funds continue to lay out A-shares
① The Abu Dhabi Investment Authority and the Kuwait Investment Authority held a large number of A-share listed companies in the first quarter; ② the Middle East Sovereign Fund also stepped up research on A-shares ③ Other overseas sovereign wealth funds are increasing their layout in the Chinese market.
Continue to “slim down”? Watch how Guo Guangchang, the head of Fosun, “crosses rapids and sails forward”
According to recent market news, following the sale of 5.6% of the shares in the Portuguese Commercial Bank (Millennium BCP) at the beginning of the year, Fosun International (00656.HK), a subsidiary of Fosun, is currently preparing to sell the remaining 20.03% of the shares.
Is Fosun Health spin-off and listed? It includes 5 major business segments
Recently, it was reported that Fosun Pharmaceutical (02196.HK) is considering spin-off Shanghai Fosun Health Technology (Group) Co., Ltd. (Fosun Health) Co., Ltd. (Fosun Health for short), which is engaged in mainland hospital business, to go public in Hong Kong and carry out a new round of financing.
Selected announcements | Cathay Pacific: The number of passengers carried in November more than tripled year-on-year; Baiyunshan's Guangzhou Pharmaceutical Fund invests in venture capital funds
China Resources Power: The subsidiary power plant sold 16.5.769 million megawatt-hours in November, an increase of 13.9% over the previous year; Tencent Holdings spent HK$401 million to repurchase 1.29 million shares on December 19.
Fosun Pharmaceutical plans to consider spin-off the hospital business “Fosun Health” and list it in Hong Kong
Bloomberg quoted news reports that Fosun Pharmaceuticals (02196.HK), a subsidiary of Fosun International (00656.HK), is considering spin-off Shanghai Fosun Health Technology (Group) Co., Ltd. (Fosun Health) Co., Ltd. (Fosun Health), which is engaged in mainland hospital business, to go public in Hong Kong and carry out a new round of financing.